Nonacus presents GALEAS ™ Bladder
Join Nonacus at the ABHI stand to explore how our flagship innovation, GALEAS™ Bladder, is transforming the bladder cancer care pathway.
Nonacus is a UK-based leader in precision oncology, headquartered in Birmingham and working with scientists and clinicians worldwide to develop end-to-end genetic testing workflows that make early cancer detection simpler, faster, and more accessible.
GALEAS™ Bladder, a non-invasive genetic test designed to help assess bladder cancer risk and support the triage of patients presenting with haematuria. By helping clinicians identify patients who require further investigation, GALEAS™ Bladder has the potential to reduce unnecessary invasive procedures, optimise clinical resources, and improve patient experience.
Where: UK Pavillion, ABHI Main Stand(S7.E50)
When: 15:10-15:40
Format: Short presentation + Q&A
Who should attend: Clinicians, Laboratory Professionals, Healthcare Leaders and Industry Partners interested in cancer diagnostics and pathway optimisation.
We look forward to meeting you and answering your questions.
Join Nonacus at the ABHI stand to explore how our flagship innovation, GALEAS™ Bladder, is transforming the bladder cancer care pathway.
Nonacus is a UK-based leader in precision oncology, headquartered in Birmingham and working with scientists and clinicians worldwide to develop end-to-end genetic testing workflows that make early cancer detection simpler, faster, and more accessible.
GALEAS™ Bladder, a non-invasive genetic test designed to help assess bladder cancer risk and support the triage of patients presenting with haematuria. By helping clinicians identify patients who require further investigation, GALEAS™ Bladder has the potential to reduce unnecessary invasive procedures, optimise clinical resources, and improve patient experience.
Where: UK Pavillion, ABHI Main Stand(S7.E50)
When: 15:10-15:40
Format: Short presentation + Q&A
Who should attend: Clinicians, Laboratory Professionals, Healthcare Leaders and Industry Partners interested in cancer diagnostics and pathway optimisation.
We look forward to meeting you and answering your questions.
Good to know
Highlights
- 30 minutes
- In person
- Doors at 3PM
Location
Dubai Exhibition Centre
Boulevard 2020
Dubai, Dubai
How do you want to get there?
Agenda
Introduce Nonacus and GALEAS™ Bladder
During this session, we will introduce GALEAS™ Bladder, a non-invasive genetic test designed to help assess bladder cancer risk and support the triage of patients presenting with haematuria.